tiprankstipranks
Advertisement
Advertisement

ALEC Stock Latest News

Alector files $400M mixed securities shelf
The FlyAlector files $400M mixed securities shelf
17d ago
ALEC
BTIG upgrades Alector to Buy on shift to novel therapeutics
PremiumThe Fly
BTIG upgrades Alector to Buy on shift to novel therapeutics
19d ago
ALEC
Alector upgraded to Buy from Neutral at BTIG
PremiumThe Fly
Alector upgraded to Buy from Neutral at BTIG
19d ago
ALEC
Buy Rating on Alector: Strategic Pivot to Blood–Brain-Barrier Platform and Emerging Alzheimer’s Assets AL137 and AL064 Underpins Attractive Risk–Reward
PremiumRatings
Buy Rating on Alector: Strategic Pivot to Blood–Brain-Barrier Platform and Emerging Alzheimer’s Assets AL137 and AL064 Underpins Attractive Risk–Reward
30d ago
ALEC
Alector: Holding Amid Pipeline Setback as ABC Brain Delivery Platform Awaits Clinical Validation
PremiumRatings
Alector: Holding Amid Pipeline Setback as ABC Brain Delivery Platform Awaits Clinical Validation
1M ago
ALEC
Alector reports Q4 EPS (34c), consensus (36c)
PremiumThe FlyAlector reports Q4 EPS (34c), consensus (36c)
1M ago
ALEC
Alector Ends Latozinemab Continuation Study: Reading the Signals for ALEC Investors
Premium
Company Announcements
Alector Ends Latozinemab Continuation Study: Reading the Signals for ALEC Investors
2M ago
ALEC
Alector price target raised to 90c from 75c at Morgan Stanley
Premium
The Fly
Alector price target raised to 90c from 75c at Morgan Stanley
3M ago
ALEC
Alector Appoints Neil Berkley as CFO
PremiumCompany Announcements
Alector Appoints Neil Berkley as CFO
4M ago
8K
ALEC
Alector names Neil Berkley as CFO, Chief Business Officer
PremiumThe Fly
Alector names Neil Berkley as CFO, Chief Business Officer
4M ago
ALEC
Cautious Outlook for Alector: Uncertainties in Clinical Validation and Financial Concerns Lead to Sell Rating
PremiumRatings
Cautious Outlook for Alector: Uncertainties in Clinical Validation and Financial Concerns Lead to Sell Rating
4M ago
ALEC
Alector price target lowered to 75c from $1.50 at Morgan Stanley
PremiumThe Fly
Alector price target lowered to 75c from $1.50 at Morgan Stanley
4M ago
ALEC
Alector’s Strategic and Financial Challenges Prompt Sell Rating Amid Clinical Setbacks
PremiumRatingsAlector’s Strategic and Financial Challenges Prompt Sell Rating Amid Clinical Setbacks
4M ago
ALEC
Alector’s Strategic Shift to ABC Platform: Promising CNS Delivery and Neurodegenerative Disease Solutions
Premium
Ratings
Alector’s Strategic Shift to ABC Platform: Promising CNS Delivery and Neurodegenerative Disease Solutions
5M ago
ALEC
Cautious Outlook on Alector Amid Strategic Shift and Uncertain Clinical Prospects
Premium
Ratings
Cautious Outlook on Alector Amid Strategic Shift and Uncertain Clinical Prospects
5M ago
ALEC
Alector, Inc. Reports Q3 2025 Financial Results
PremiumCompany Announcements
Alector, Inc. Reports Q3 2025 Financial Results
5M ago
ALEC
Cautious Hold on Alector Amid Strategic Shift and Long-term Focus
PremiumRatings
Cautious Hold on Alector Amid Strategic Shift and Long-term Focus
5M ago
ALEC
Alector reports Q3 EPS (34c), consensus (41c)
PremiumThe Fly
Alector reports Q3 EPS (34c), consensus (41c)
5M ago
ALEC
Alector’s Latozinemab Study: A Promising Continuation for Neurodegenerative Disease Treatment
PremiumCompany Announcements
Alector’s Latozinemab Study: A Promising Continuation for Neurodegenerative Disease Treatment
5M ago
ALEC
Alector’s Strategic Potential in Biotechnology: Buy Rating Justified Despite Price Target Reduction
PremiumRatingsAlector’s Strategic Potential in Biotechnology: Buy Rating Justified Despite Price Target Reduction
5M ago
ALEC
Alector price target lowered to $5 from $10 at H.C. Wainwright
Premium
The Fly
Alector price target lowered to $5 from $10 at H.C. Wainwright
5M ago
ALEC
Alector downgraded to Neutral from Buy at BTIG
Premium
The Fly
Alector downgraded to Neutral from Buy at BTIG
5M ago
ALEC

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >